These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 32517799)

  • 1. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.
    Baldini F; Hertel J; Sandt E; Thinnes CC; Neuberger-Castillo L; Pavelka L; Betsou F; Krüger R; Thiele I;
    BMC Biol; 2020 Jun; 18(1):62. PubMed ID: 32517799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's Disease and the Gut Microbiome in Rural California.
    Zhang K; Paul KC; Jacobs JP; Chou HL; Duarte Folle A; Del Rosario I; Yu Y; Bronstein JM; Keener AM; Ritz B
    J Parkinsons Dis; 2022; 12(8):2441-2452. PubMed ID: 36442206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
    Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
    Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson's Disease.
    Metcalfe-Roach A; Cirstea MS; Yu AC; Ramay HR; Coker O; Boroomand S; Kharazyan F; Martino D; Sycuro LK; Appel-Cresswell S; Finlay BB
    Mov Disord; 2024 Oct; 39(10):1740-1751. PubMed ID: 39192744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
    Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
    Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients.
    Gorecka-Mazur A; Krygowska-Wajs A; Furgala A; Li J; Misselwitz B; Pietraszko W; Kwinta B; Yilmaz B
    Neurogastroenterol Motil; 2024 Aug; 36(8):e14846. PubMed ID: 38873926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
    Tan AH; Chong CW; Lim SY; Yap IKS; Teh CSJ; Loke MF; Song SL; Tan JY; Ang BH; Tan YQ; Kho MT; Bowman J; Mahadeva S; Yong HS; Lang AE
    Ann Neurol; 2021 Mar; 89(3):546-559. PubMed ID: 33274480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiome in Parkinson's disease: New insights from meta-analysis.
    Toh TS; Chong CW; Lim SY; Bowman J; Cirstea M; Lin CH; Chen CC; Appel-Cresswell S; Finlay BB; Tan AH
    Parkinsonism Relat Disord; 2022 Jan; 94():1-9. PubMed ID: 34844021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease.
    Hertel J; Harms AC; Heinken A; Baldini F; Thinnes CC; Glaab E; Vasco DA; Pietzner M; Stewart ID; Wareham NJ; Langenberg C; Trenkwalder C; Krüger R; Hankemeier T; Fleming RMT; Mollenhauer B; Thiele I
    Cell Rep; 2019 Nov; 29(7):1767-1777.e8. PubMed ID: 31722195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
    Qian Y; Yang X; Xu S; Wu C; Song Y; Qin N; Chen SD; Xiao Q
    Brain Behav Immun; 2018 May; 70():194-202. PubMed ID: 29501802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson's disease.
    Park DG; Kang W; Shin IJ; Chalita M; Oh HS; Hyun DW; Kim H; Chun J; An YS; Lee EJ; Yoon JH
    Neurobiol Dis; 2024 Oct; 201():106655. PubMed ID: 39218360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease.
    Cirstea MS; Yu AC; Golz E; Sundvick K; Kliger D; Radisavljevic N; Foulger LH; Mackenzie M; Huan T; Finlay BB; Appel-Cresswell S
    Mov Disord; 2020 Jul; 35(7):1208-1217. PubMed ID: 32357258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
    Mertsalmi TH; Aho VTE; Pereira PAB; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    Eur J Neurol; 2017 Nov; 24(11):1375-1383. PubMed ID: 28891262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting gut-brain axis through scalp-abdominal electroacupuncture in Parkinson's disease.
    Nazarova L; Liu H; Xie H; Wang L; Ding H; An H; Huang D
    Brain Res; 2022 Sep; 1790():147956. PubMed ID: 35660372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.